S. 5123 · 117th Congress
Breakthrough Therapies Act
- Stage
- In committee
- Sponsor
- Cory Booker
- Introduced
- 2022-11-17
- Latest action
- 2022-11-17 · Introduced in Senate
Summary
Breakthrough Therapies Act
This bill provides for the classification of drugs or other substances that are part of approved breakthrough therapies as schedule II controlled substances under the Controlled Substances Act. It also provides for expedited controlled substance registrations through the Drug Enforcement Administration for researchers whose work involves investigational drugs.